Mirae Asset Global ETFs Holdings’s Royalty Pharma RPRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.5M	Sell	259,390 -159,739	-38%	-$8.31M	0.02%	585
2026 Q1	$20.1M	Buy	419,129 +9,433	+2%	+$413K	0.03%	479
2025 Q4	$15.8M	Buy	409,696 +148,402	+57%	+$5.66M	0.02%	515
2025 Q3	$9.22M	Buy	261,294 +245,845	+1,591%	+$8.9M	0.01%	653
2025 Q2	$557K	Sell	15,449 -64,541	-81%	-$2.14M	﹤0.01%	1769
2025 Q1	$2.49M	Buy	79,990 +13,489	+20%	+$428K	0.01%	1024
2024 Q4	$1.7M	Buy	66,501 +13,376	+25%	+$355K	﹤0.01%	1237
2024 Q3	$1.5M	Buy	53,125 +4,935	+10%	+$137K	﹤0.01%	1308
2024 Q2	$1.27M	Buy	+48,190	New	+$1.34M	﹤0.01%	1330

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RPRX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Royalty Pharma (RPRX) stake by 38% in Q2 2026, selling an estimated $8.31M and leaving 259,390 shares worth $14.5M. The position accounts for 0.02% of the portfolio, ranked #585.

Mirae Asset Global ETFs Holdings first reported a position in RPRX in Q2 2024 and has held it in 9 quarters since. The position peaked at $20.1M in Q1 2026. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 259,390 shares of Royalty Pharma worth $14.5M as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 159,739 Royalty Pharma shares in Q2 2026, an estimated $8.31M.
Royalty Pharma made up 0.02% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #585 holding.
Mirae Asset Global ETFs Holdings first reported a position in Royalty Pharma in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Royalty Pharma position peaked at $20.1M in Q1 2026.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.